Skip to main content

Prolia 60mg | Prolia 60mg Injections | denosumab | Apple pharmaceuticals

Prolia 60mg | Prolia 60mg Injections | denosumab  

Apple pharmaceuticals


Prolia 60mg | Prolia 60mg Injections



Prolia 60mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides.

PRESCRIBED FOR
Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture. Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic prostate cancer. Treatment for patients having to increase bone mass in women at more risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer.

DOSAGE

For adult :
Osteoporosis :
60mg SC (subcutaneously) once every 6 months
Injection of drug should be done in upper arm, upper thigh or abdomen
Giant Cell Tumor of bone :
120mg SC, every 4 weeks with additional 120mg doses on days 8 and 15 of the 1st month treatment
Injection of drug should be done in upper arm, upper thigh or abdomen
Osteolytic Bone Metastases of Solid Tumors :
120mg subcutaneously every 4 weeks
Injection of drug should be done in upper arm, upper thigh or abdomen
Hypercalcemia :
Dose of 120mg Prolia tablet given SC, every 4 weeks with additional 120mg doses on days 8 and 15 of the 1st month treatment
Injection of drug should be done in upper arm, upper thigh or abdomen
Dosage and administration in pediatric :
13 years and older and 45kg or more
Giant Cell Tumor of bone:
Dose of 120mg Prolia tablet given SC, every 4 weeks with additional 120mg doses on days 8 and 15 of the 1st month treatment
OVERDOSE: 
Prolia overdose has no overdose. If occurs seek to emergency department and call poison control


MECHANISM

Denosumab linked to RANKL, a protein which is specific for the formation, function and survival of osteoclasts, the cells necessary for bone resorption. Denosumab prohibits osteoclast formation, function and survival hence, reducing bone resorption and raising bone mass and strength of the bone.


ADME

Peak plasma concentration: 6.75mcg/mL
Tmax : 10days
Without aggregation in Prolia pharmacokinetics with duration was noticed upon multiple dosing of 60 mg SC administered once every 6 months. Pharmacokinetics of Prolia will not affected by the binding antibodies formation.
Half-life is 25.4 days.


PRECAUTION

• Before to start treatment with Prolia, discuss with the doctor about any other regimens you are using (including over-the-counter drugs, vitamins, or herbal remedies). Do not take aspirin or products containing aspirin unless your doctor permits this.
Prolia injection may improve the negative effects of immuno-suppressants. Especially the risk for serious infections may be increased. Inform your doctor of any immuno-suppressive drugs you early consume.
• Not to receive any type of vaccination without your doctor's consultation while admonishing denosumab.
• Use in pregnancy only if benefit to mother outweighs risk to fetus. Consult with doctor before the treatment
• During Prolia treatment do not breastfeed your infants.


DRUG INTERACTION


No formal drug-drug interaction with denosumab during trials.
When interacting with some anticancer drug, orthopedic drugs, vaccines will lead to risk of adverse effects can be increased


CONTRAINDICATION

Prolia is contraindicated in patients having Hypocalcemia, Pregnancy, Hypersensitivity


LACTATION

Prolia 60mg is excreted into human milk is not known. Since possible for severe side effects occurs in nursing infants from Prolia 60mg injection, a decision should be considered that to discontinue nursing or discontinue the drug by giving preference of the importance of the drug to the mother.


STORAGE

Store at 2℃ to 8℃ in the original container, avoid freeze
Before to administration keep at room temperature
Prolia protect from direct light and heat.


MISSED DOSE

Take the dose immediately before next dose duration, then left off the missed dose and continue regular schedule.Avoid taking double dose at same time. Please consult the doctor for further information.


SIDE EFFECTS


Common side effects for the patient taking Prolia 60mg as follows : Fatigue, Muscle weakness, Phosphorus level reduced in blood, Nausea
Less common side effects for patients taking Prolia:
Dyspnea, Hypocalcemia, Cough, Arthralgia, Limb pain, Eczema, Headache


Contact Us


phone No      :9987711567

Email             :info@myapplepharma.com


website         

https://myapplepharma.com/prolia-60mg.php

Comments

Popular posts from this blog

Afatinib 20mg | Afatinib 20mg tablet | Xovoltib | Apple pharmaceuticals

Afatinib 20mg | Afatinib 20mg tablet   Apple pharmaceuticals Afatinib 20mg | Afatinib 20mg tablet |  Xovoltib 20mg | Xovoltib 20mg tablet Afatinib 20mg tablet Xovoltib 20mg  belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Xovoltib 20mg  is a prescription drugs which is used under the guidance of medical practioners. INDICATION Xovoltib 20mg  is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. DOSAGE Xovoltib the prescribed dose for the treatment of non-small cell lung cancer as follows : For adult : The prescribed dose is 40mg taken once per day. For child dosage : Ages of 0-17 years is not being studied in children. The drug should not be used age under 18 years of a...

Afatinib 20mg | Afatinib 20mg tablet | Xovoltib | Apple pharmaceuticals

Afatinib 20mg |  Afatinib 20 mg comprimat   Produse farmaceutice Apple Afatinib 20mg  |  Afatinib 20 mg comprimat  |  Xovoltib 20mg  |  Tableta Xovoltib 20mg Afatinib 20 mg comprimat Xovoltib 20mg   aparține derivatului de chinazolină și butanamidă, care acționează ca un inhibitor al tirozin kinazei a receptorilor factorilor de creștere a epidermiei (RECEPTORI ERBB) și este utilizat în tratamentul CANCERULUI  LUNGULUI CU CELULE MICIUNE MICASTIC  . Xovoltib 20mg   este un medicament care se eliberează pe bază de rețetă, care este utilizat sub îndrumarea practicienilor medicali. INDICAŢIE Xovoltib 20mg   este indicat pentru tratamentul unui anumit tip de cancer pulmonar (cancer pulmonar cu celule mici) care s-a răspândit în alte părți ale corpului. DOZARE Xovoltib doza prescrisă pentru tratamentul cancerului pulmonar cu celule mici, după cum urmează: Pentru adult: ...

Tasigna 150mg (Nilotinib) capsules | Apple pharmaceuticals

Tasigna 150mg (Nilotinib) capsules Apple pharmaceuticals  Tasigna 150mg | Tasigna 150mg  capsules | Nilotinib 150mg | Nilotinib150mg capsules description Tasigna 150mg  is cancer drugs, the main ingredient which is used as  lapatinib , which prohibits growth of the tumor cells. Nilotinib is sold under the brand name  Tasigna  which is a targeted cancer medication Tasigna tablet belongs to the class of kinase inhibitors. The medicine Tasigna in children younger than 1 year has  Tasigna 150mg  capsules  no safety and efficacy not been established The drug Tasigna is a prescription drugs, which is used under the knowledge of medical oncologist. DOSAGE The usual dose of  Tasigna  Tablet should be given as twice daily at 12 hours time intervals Tasigna must be administer on an empty stomach Taking of food should not be at least 1 hour after the dose is taken or 2 hours before the dose is taken Who are unable to ta...